Skip to main content
OpenTrials
Completed

NCT Number: NCT05978076

Serum Lipase and Severity of Pancreatic Injury.

Diagnosis of pancreas injury is not easy at first consult. It's a retrospective study, in children under 15 years and 3months, between January 1st 2010 to August 31th 2019, to prove that the first level of lipase is correlated with the severity of pancreatic injury.

Every children with elevated serum lipase after trauma during those years will be selected.

The children with pancreatic tumors will be excluded. American Association of Surgeon Trauma (AAST) classification of pancreas injury will be used to grade severity.

Children will be divided in two groups : one including pancreatic lesion with duct injury and one without duct injury.

Data will include mechanism of injury, associated injury, length of stay, maximal lipase level, nutritional care and local complications will be noted.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatic Injury

Age range

Up to 15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Saint-Etienne

Saint-Etienne, France

About this study

The main objective of this study is to determine if there is a correlation between the initial serum lipase and the severity of the pancreatic injury.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children under 15 years 3 months with elevated lipase serum level after trauma.

Exclusion criteria

  • Elevation of lipase secondary to pancreatic tumor

Treatment and study plan

Data Collection

Other

data collection : mechanism of injury, associated injury, length of stay, maximal lipase level, nutritional care and local complications.

Primary outcomes

  1. lipase level in severe pancreatic injury (duct injury)

    Time frame: Month: 9 (end of study)

    Collected in medical history.

  2. lipase level in light pancreatic injury (without duct injury)

    Time frame: Month: 9 (end of study)

    Collected in medical history.

Secondary outcomes

  1. Local complications

    Time frame: Month: 9 (end of study)

    Collected in medical history.

  2. Maximal lipase level

    Time frame: Month: 9 (end of study)

    Collected in medical history.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Aug 7, 2023
Registry last updated
Aug 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.